arrow
S

Sang-Yong Yoo

yonsei university health system
H指数:14
被引数:1,363

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anatomical Snuffbox Versus Dorsum of the Hand for Optimal Access Site in Distal Radial Access: Insight From the KODRA Registry

解剖学鼻烟盒与手背在远端桡动脉入路中的最佳入路部位比较:来自KODRA注册研究的见解

2026-01-011
OA
Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION–STEMI): a multicentre, non-inferiority, open-label, randomised trial

在ST段抬高型心肌梗死合并多支血管病变患者首次入院期间,即刻与分阶段完全血运重建的比较(OPTION–STEMI):一项多中心、非劣效性、开放标签、随机试验

2025-08-310
PRE
Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial
2024-07-010
OAAI
Ticagrelor Monotherapy After 3-Month Dual Antiplatelet Therapy in Acute Coronary Syndrome by High Bleeding Risk: The Subanalysis From the TICO Trial
2022-01-0116
OAAI
Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Patients With ST-Segment Elevation Myocardial Infarction
2021-02-0119
OAAI
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome The TICO Randomized Clinical Trial
2020-06-16381
OAAI
High-intensity Statin Treatments in Clinically Stable Patients on Aspirin Monotherapy 12 Months After Drug-eluting Stent Implantation: A Randomized Study
2018-06-0111
PREAI
Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve)
2017-06-06148
OAAI
Bioresorbable Vascular Scaffold Korean Expert Panel Report
2017-01-017
OAAI
Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial
2015-08-013
PREAI
Efficacy of cilostazol on inhibition of platelet aggregation, inflammation and myonecrosis in acute coronary syndrome patients undergoing percutaneous coronary intervention: The ACCEL-LOADING-ACS (ACCELerated Inhibition of Platelet Aggregation, Inflammation and Myonecrosis by Adjunctive Cilostazol Loading in Patients With Acute Coronary Syndrome) study

西洛他唑对接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者的血小板聚集,炎症和肌坏死的抑制作用: accel-load-acs (急性冠状动脉综合征患者西洛他唑负荷对血小板聚集,炎症和肌坏死的加速抑制) 研究

2015-07-0111
PREAI